Abstract

Pulmonary arterial hypertension is one of the clinical groups of arterial hypertension. It is a rare, chronic disease with a very poor prognosis. Diagnostic procedures ruling out different causes of present symptoms and other forms of pulmonary hy pertension are difficult and specific. Current European guidelines recommend combined treatment with endothelin recep tor antagonist, prostanoids, and phosphodiesterase type 5 inhibitors.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call